• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高脂肪餐对盐酸丙哌维林控释片和普通片生物利用度的影响。

Influence of a fat-rich meal on bioavailability of extended-release and immediate-release propiverine.

机构信息

Department of Clinical Pharmacology, Ernst Moritz Arndt University, Friedrich-Loeffler-Str. 23d, D-17487 Greifswald, Germany.

出版信息

J Clin Pharmacol. 2012 May;52(5):681-90. doi: 10.1177/0091270011401260. Epub 2011 May 6.

DOI:10.1177/0091270011401260
PMID:21551317
Abstract

The muscarinic receptor antagonist propiverine is unique insofar as extended-release (ER) tablets are of higher bioavailability than immediate-release (IR) tablets; this is caused by lower "first-pass" elimination of propiverine via CYP3A4 and efflux transporters in the distal small intestine and colon. Food may influence gastrointestinal transiting and, in turn, may affect regional absorption of propiverine IR and ER. Therefore, food effects on disposition of 30 mg IR and 45 mg ER were measured in a randomized, open, 4-period interaction study in 24 healthy participants. In fasting participants, ER had higher bioavailability than IR (F(rel) = 169%, P = .03). Fat-rich meal did not change the disposition of ER markedly (AUC(0-∞) ratio, 1.00 [90% confidence interval (CI), 0.90-1.11], C(max) ratio, 0.97 [0.87-1.09]). However, C(max) and renal A(e) of the major N-oxidized metabolite (M-5) significantly increased, whereas t(1/2) decreased. By eating a fat-rich meal before administration, the differences in absorption of IR and ER were nearly abolished (AUC(0-∞) ratio for propiverine, 1.12 [90% CI, 0.95-1.33]; AUC(0-∞) ratio for M-5, 0.89 [0.82-0.95]). In conclusion, propiverine ER has higher bioavailability than IR and no positive food effect because it reaches, independently of food, intestinal absorption areas with lower metabolism and efflux transport, which results in constant absorption rates.

摘要

抗毒蕈碱受体拮抗剂丙哌维林的特点是,其缓释片的生物利用度高于速释片;这是由于丙哌维林通过 CYP3A4 和远段小肠及结肠中的外排转运体的“首过”消除率降低所致。食物可能会影响胃肠道转运,进而可能会影响丙哌维林速释和缓释片的局部吸收。因此,在 24 名健康参与者中进行了一项随机、开放、4 周期相互作用研究,以评估食物对 30mg 速释片和 45mg 缓释片处置的影响。在禁食参与者中,缓释片的生物利用度高于速释片(F(rel) = 169%,P =.03)。高脂肪餐并未明显改变缓释片的处置(AUC(0-∞) 比值,1.00[90%置信区间(CI),0.90-1.11];C(max)比值,0.97[0.87-1.09])。然而,主要 N-氧化代谢产物(M-5)的 C(max)和肾 A(e)显著增加,而 t(1/2)缩短。进食高脂肪餐会使速释和缓释片的吸收差异几乎消失(丙哌维林的 AUC(0-∞)比值,1.12[90%CI,0.95-1.33];M-5 的 AUC(0-∞)比值,0.89[0.82-0.95])。总之,丙哌维林缓释片的生物利用度高于速释片,且不受食物的影响,因为它独立于食物到达代谢和外排转运较低的肠吸收部位,从而导致吸收速率恒定。

相似文献

1
Influence of a fat-rich meal on bioavailability of extended-release and immediate-release propiverine.高脂肪餐对盐酸丙哌维林控释片和普通片生物利用度的影响。
J Clin Pharmacol. 2012 May;52(5):681-90. doi: 10.1177/0091270011401260. Epub 2011 May 6.
2
Modeling the heterogeneous intestinal absorption of propiverine extended-release.丙哌维林缓释片肠道吸收异质性的建模
Eur J Pharm Sci. 2015 Aug 30;76:133-7. doi: 10.1016/j.ejps.2015.05.010. Epub 2015 May 11.
3
Oral absorption of propiverine solution and of the immediate and extended release dosage forms: influence of regioselective intestinal elimination.丙哌维林溶液以及速释和缓释剂型的口服吸收:区域选择性肠道消除的影响
Eur J Clin Pharmacol. 2008 Nov;64(11):1085-92. doi: 10.1007/s00228-008-0528-0. Epub 2008 Jul 15.
4
Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.500毫克克拉霉素缓释片两种制剂在空腹和进食条件下的生物等效性评估:一项在健康约旦男性志愿者中进行的单剂量、随机、开放标签、两周期、双向交叉研究。
Clin Ther. 2008 Oct;30(10):1831-43. doi: 10.1016/j.clinthera.2008.10.010.
5
Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults.盐酸沙丙蝶呤片完整片和溶解片的相对生物利用度及食物的影响:一项在健康成年人中开展的随机、开放标签、交叉研究。
Clin Ther. 2010 Feb;32(2):338-46. doi: 10.1016/j.clinthera.2010.02.012.
6
Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studies.健康男性志愿者中每日 1 次给予盐酸普拉克索控释片的药代动力学:3 项研究。
Clin Ther. 2009 Nov;31(11):2698-711. doi: 10.1016/j.clinthera.2009.10.018.
7
Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states.灰黄霉素冻干干乳剂片与速释片的相对生物利用度:一项在健康成年志愿者禁食和进食状态下进行的单剂量、随机、开放标签、六周期交叉研究。
Eur J Pharm Sci. 2008 Oct 2;35(3):219-25. doi: 10.1016/j.ejps.2008.07.002. Epub 2008 Jul 15.
8
Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.评估3种不同饮食对2种缓释茶碱基质片生物利用度的影响。
Int J Clin Pharmacol Ther. 1997 Dec;35(12):565-71.
9
Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.饮食对 dalcetrapib 药代动力学特性的影响:来自健康志愿者的三项 I 期、单次交叉研究的结果。
Clin Ther. 2011 Jun;33(6):754-65. doi: 10.1016/j.clinthera.2011.05.046.
10
Disposition and antimuscarinic effects of the urinary bladder spasmolytics propiverine: influence of dosage forms and circadian-time rhythms.
J Clin Pharmacol. 2008 May;48(5):570-9. doi: 10.1177/0091270008315314. Epub 2008 Mar 4.

引用本文的文献

1
Medication use and the risk of motor vehicle collision in West Virginia drivers 65 years of age and older: a case-crossover study.西弗吉尼亚州65岁及以上驾驶员的药物使用与机动车碰撞风险:一项病例交叉研究。
BMC Res Notes. 2016 Mar 15;9:166. doi: 10.1186/s13104-016-1974-x.
2
Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms.普罗哌瑞林:一项用于治疗成人和儿童伴特发性或神经源性逼尿肌过度活动的膀胱过度活动症,以及用于治疗男性下尿路症状的综述。
Clin Drug Investig. 2013 Jan;33(1):71-91. doi: 10.1007/s40261-012-0046-9.